Nuclear Receptors, Inflammation, and Liver Disease: Insights for Cholestatic and Fatty Liver Diseases
- 3 March 2010
- journal article
- review article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 87 (4), 473-478
- https://doi.org/10.1038/clpt.2010.2
Abstract
Members of the nuclear receptor (NR) superfamily of ligand‐activated transcription factors are players of substantial relevance in the regulation of hepatic gene expression. NRs direct normal physiology and metabolism, adaptations to liver disease, and responses to inflammation and toxins. They also contribute to the regenerative response. In this review, we summarize currently available experimental and clinical data, focusing on the role of NRs in cholestasis and nonalcoholic fatty liver disease (NAFLD). We also highlight the potential of NRs as targets for safe and effective therapeutic interventions.Keywords
This publication has 37 references indexed in Scilit:
- Nuclear receptors: mediators and modifiers of inflammation-induced cholestasisFrontiers in Bioscience-Landmark, 2009
- Nuclear receptors as therapeutic targets in cholestatic liver diseasesBritish Journal of Pharmacology, 2008
- Nuclear bile acid receptor farnesoid X receptor meets nuclear factor-κB: New insights into hepatic inflammationJournal of Hepatology, 2008
- Physiology and pathophysiology of liver inflammation, damage and repair.2008
- Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory responseJournal of Hepatology, 2008
- Nuclear factor- B inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapyGut, 2008
- The Role of Insulin Resistance in Nonalcoholic Fatty Liver DiseaseJournal of Clinical Endocrinology & Metabolism, 2006
- Principles for modulation of the nuclear receptor superfamilyNature Reviews Drug Discovery, 2004
- Enhanced expression of basolateral multidrug resistance protein isoforms Mrp3 and Mrp5 in rat liver by LPSBiological Chemistry, 2004
- Endotoxin leads to rapid subcellular re-localization of hepatic RXRα: A novel mechanism for reduced hepatic gene expression in inflammationNuclear Receptor, 2004